Psilocybin has better response than placebo in antidepressant trials
By
Haymarket Media
Aug 28, 2024
Only high-dose psilocybin was better than placebo in antidepressant trials of escitalopram.
Extended-release oral ketamine effective for treatment-resistant depression
Jul 17, 2024
Excellent tolerability was seen, with no changes in blood pressure, minimal reports of sedation and minimal dissociation.
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
Some environmental toxicants linked to depressive symptoms
Jul 09, 2024
Six of 10 categories of environmental toxicants were linked to the prevalence of depressive symptoms.
Bidirectional link ID’d for change in depressive symptoms, memory change
Jun 13, 2024
A steeper change in depressive symptoms was linked to accelerated memory change and vice versa.
Anxiety, depression associated with gastroesophageal reflux disease
Apr 02, 2024
Causal relationship were seen for the moderately severe anxiety group with increased GERD incidence.
Mental health treatment linked to better outcomes in CAD, heart failure
Mar 22, 2024
Patients receiving mental health treatment were less likely to be rehospitalized, have an emergency department visit or die from any cause.